# OnCo record stephenson-oklahoma (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/stephenson-oklahoma/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "stephenson-oklahoma" ;
  schema:name "Stephenson Cancer Center, OU Health"@en ;
  schema:description "Oklahoma's only NCI-designated centre, consistently among the top enrollers in NRG gynaecologic trials and home of the SOLO1 and MIRASOL ovarian cancer lead investigator."@en ;
  schema:url <https://onco.cc/institutions/stephenson-oklahoma/>, <https://www.ouhealth.com/stephenson-cancer-center/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.ouhealth.com/stephenson-cancer-center/>, <https://www.ouhealth.com/stephenson-cancer-center/research-clinical-trials/> ;
  schema:addressCountry "US" ;
  schema:addressLocality "Oklahoma City, OK" ;
  schema:latitude "35.48"^^xsd:decimal ;
  schema:longitude "-97.497"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/endometrial/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/parp/>, <https://onco.cc/targets/folr1/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/mirvetuximab-soravtansine/> ;
  onco:companies <https://onco.cc/companies/nrg-oncology/> ;
  onco:people <https://onco.cc/people/kathleen-moore/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-diversity/> .